Literature DB >> 2177721

[The serotonin hypothesis of depression].

K P Lesch1, H Beckmann.   

Abstract

Current theoretical and experimental developments in serotonin research extend from the differentiated description of central cytoarchitectonic structures over the identification and characterization of multiple receptor subtypes by pharmacological and molecular biological methods to the elucidation of neurobiochemical and physiological mechanisms of interneuronal communication and postreceptor signal transduction. These advances parallel the modification and optimization of various strategies for researching the relevance of central serotonergic neurotransmission in the aetiopathogenesis of affective disorders. Strategies such as the paradigm of selective pharmacological provocation contribute significantly to the formulation of complex hypotheses on the physiological regulation of receptor sensitivity, on receptor function in depression and on the processes of therapeutically induced neuroadaptation. In addition it appears that the generation of hypotheses receives further input from fundamental advances at the level of molecular pharmacology and biology. Reviewing and integrating our current knowledge to define the present state of the art facilitates the assessment of the position of serotoninergic function in the pathophysiology of affective disorder and in the mechanisms of action of various therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177721     DOI: 10.1055/s-2007-1001206

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  2 in total

1.  Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours.

Authors:  Ekaterini Blaveri; Fiona Kelly; Alessandra Mallei; Kriss Harris; Adam Taylor; Juliet Reid; Maria Razzoli; Lucia Carboni; Chiara Piubelli; Laura Musazzi; Girogio Racagni; Aleksander Mathé; Maurizio Popoli; Enrico Domenici; Stewart Bates
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

Review 2.  Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma.

Authors:  Antonio Inserra; Claudio Alberto Mastronardi; Geraint Rogers; Julio Licinio; Ma-Li Wong
Journal:  Mol Neurobiol       Date:  2018-10-10       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.